239
Participants
Start Date
February 28, 2017
Primary Completion Date
November 17, 2017
Study Completion Date
December 6, 2017
IX-01 400 mg
IX-01 400 mg caplet
Placebo
Placebo caplet(s)
IX-01 800 mg
IX-01 800 mg (Two 400 mg caplets)
IX-01 1200 mg
IX-01 1200 mg (Three 400 mg caplets)
Manhattan Medical Research, New York
Drug Trials America, Hartsdale
Urologic Consultants of Southeastern Pennsylvania, Bala-Cynwyd
Radiant Research, Inc. - Anderson, Anderson
Radiant Research, Inc. - Greer, Greer
Northwest Behavioral Research Center, Roswell
A G A Clinical Trials, Hialeah
Clinical Research Center of Florida, Pompano Beach
South Florida Medical Research Inc., Aventura
Center for Marital and Sexual Health of South Florida, West Palm Beach
Coastal Clinical Research Inc, Mobile
Radiant Research, Inc. - Columbus, Columbus
Radiant Research, Inc. - Akron, Akron
Radiant Research, Inc. - Cincinnati, Cincinnati
Center For Pharmaceutical Research, Kansas City
Radiant Research, Inc. - Dallas, Dallas
Clinical Trials of Texas Incorporated, San Antonio
Radiant Research Inc - San Antonio, San Antonio
Columbine Family Practice - Radiant, Littleton
Radiant Research, Inc. - Salt Lake City, Murray
Family Practice Specialists - Radiant, Phoenix
Desert Clinical Research, LLC - Radiant, Mesa
Radiant Research, Inc. - Phoenix SE, Chandler
Clifford J Molin MD LTD - Radiant, Las Vegas
San Diego Sexual Medicine, San Diego
Boston Clinical Trials Inc, Boston
Mens Health Boston, Chestnut Hill
Accumed Research Associates, Garden City
Miriam Hospital / The Men's Health Center, Providence
Ixchelsis Limited
INDUSTRY